覃丽 - 湖南中医药大学

个人简介

湖南省青年骨干教师。湖南省药学重点学科学术带头人。相继获得湖南省自然科学基金杰出青年基金、中法施维雅青年药理学家奖、全国高等中医药院校“优秀青年”称号、湖南省青年科技奖、中国药理学会优秀青年药理学工作者奖以及湖南省“芙蓉百岗明星”称号等。担任中国生物化学与分子生物学会脂质与脂蛋白专业委员会青年委员、中国药理学会心血管专业委员会第一届青年委员会、湖南省药学会中药天然药物专业委员会常务委员，中国药理学会补益药药理专业委员会委员，世界中医药学会联合会网络药理学专业委员会理事，湖南省药理学会理事、国家自然科学基金同行评议专家。从事药理学的教学及科研工作18年。主讲《药理学》、《临床药理学》、《临床药物治疗学》、《生物制品学》等本科生课程，以及留学生《药理学》全英文课程。发表教学论文26篇，主持教改课题4项。

研究领域

主要从事脂质异常相关疾病发病机制及其中医药防治研究。

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

[1] Jia Long#，Neng Zhu#, Chan-Juan Zhang#, Ke Du , Yu-FangYin, Xi Tan,Li Qin*，Duan-Fang Liao. Lipid Metabolism and Carcinogenesis, Cancer Development. American Journal of Cancer Research. 2018. (Accepted) [2] Ya-Ning Shi, Neng Zhu, Chan Liu, Yu Gui, Duan-Fang Liao,Li Qin*.Wnt5a and Its Signaling Pathway in Angiogenesis. Clin Chim Acta. 2017,471:263-269 [3]Qin L,Liu C, Ni YG, Shi YN, Ao BX, Liu Z, Liao DF.WNT5A/ROR2 SUPPRESSES THE PROLIFERATION OF SMOOTH MUSCLE CELL VIA PKC SIGNALING PATHWAY.J Hypertens. 2016 Sep;34 Suppl 1 -ISH 2016:e49-e50. [4]Chan Liu, Hong-Tao Wu, Neng Zhu, Ya-Ning Shi, Zheng Liu, Bao-Xue Ao, Duan-Fang Liao, Xi-Long Zheng,LiQin*. Steroid receptor RNA activator: Biologic function and role in disease. Clin Chim Acta. 2016 Jun 6. 459:137-146 [5]Li Qin, Neng Zhu, Bao-Xue Ao, Chan Liu, Ya-Ning Shi, Ke Du, Jian-Xiong Chen, Xi-Long Zheng, Duan-Fang Liao. Caveolae and Caveolin-1 Integrate the Reverse Cholesterol Transport and Inflammation in Atherosclerosis.International Journal of Molecular Sciences. 2016，Mar 22;17(3). pii: E429. doi:10.3390/ ijms 17030429 [6]Li QIN,Yun-bo YANG, Yi-xin YANG, Neng ZHU, Shun-xiang LI, Duan- fang LIAO. Inhibition of macrophage derived-foam cell formation by ezetimibe via caveolin-1/MAPK pathway. Clinical and Experimental Pharmacology and Physiology. 2016 Feb;43(2):182-92 [7]Li Qin, Yan-Tao Yin ,Fang-Jing Zheng , Li-Xia Peng, Guang-Da Yang,Ying-Na Bao, Xin-Jian Li, Yan-Qun Xiang, An-Hua Li, Ru-Hai Zou, Xiao-Qing Pei,Tie-Bang Kang, Duan-Fang Liao, Yi-Xin Zeng, Chao-Nan Qian. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis. Oncotarget. 2015. Apr 30;6(12):10239-10252. [8]Li Qin,Yun-Bo Yang, Yi-Xin Yang, Neng Zhu, Shun-Xiang Li, Duan- Fang Liao, Xi-Long Zheng. Anti-inflammatory activity of ezetimibe by regulating NF-κB/MAPK pathway in THP-1 macrophages. Pharmacology;2014;93 (1-2): 69-75. [9]Li Qin, Rong Hu, Neng Zhu, Hai-Lun Yao, Xiao-Yong Lei, Shun-XiangLi, Duan-Fang Liao, Xi-Long Zheng. The Novel Role and Underlying Mechanism of Wnt5a in Regulating Cellular Cholesterol Accumulation. Clinical and Experimental Pharmacology and Physiology. 2014 Sep;41(9):671-8. [10]Li QIN,Yun-bo YANG, Yi-xin YANG, Neng ZHU, Shun-xiang LI, Duan-fang LIAO. Ezetimibe suppresses cholesterol accumulation in lipid-loaded vascular smooth muscle cells in vitro via MAPK signaling Acta Pharmacologica Sinica. 2014;35(9):1129-36 [11]NENG ZHU,LI QIN*,ZHIGANG LUO, QIONG GUO, LUOYAN YANG, DUANFANG LIAO. Challenging role of Wnt5a and its signaling pathway in cancer metastasis. Experimental and Therapeutic Medicine. 2014,8（1）：3-8. [12]Li Qin，Yun-Bo Yang，Yi-Xin Yang，Yong-Zhen Gong，Xiao-Ling Li，Gui-Yuan Li，Hong-Dan Luo，Xue-Jiao Xie, Xi-Long Zheng，Duan-Fang Liao. Inhibition of Smooth Muscle Cell Proliferation by Ezetimibe via Cyclin D1-MAPK pathway. Journal of Pharmacological Sciences. 2014, 125（3）: 283-291. [13]Qin L,Bromberg-White JL, Qian CN. Opportunities and challenges in tumor angiogenesis research: Back and forth between bench and bed. Advances in Cancer Research.2012;113:191-239 [14]Qin L，Yang YB, Tuo QH, Zhu BY, Chen LX, Zhang L, Liao DF. Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cell induced by Chol:MßCD.Biochem Biophys Res Commun.2009; 379 (2): 277-282. [15]Qin L,Zhang X,Zhang L,Feng Y,Weng GX,Li MZ,Kong QL,Qian CN,Zeng YX,Zeng MS,Liao DF,Song LB. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells.Biochem Biophys Res Commun.2008，371（3）：531-535 [16]Qin Let al. The involvement of caveolae/caveolin-1 on activation of ERK1/2 induced by angiotensinII in vascular smooth muscle cells. Acta Pharmacol Sin.2006，27（supplement 1）: 403